Dated this [ ] B E T W E E N : (as Chargor) AND GOLDEN MEDITECH STEM CELLS (BVI) LIMITED (as Chargee) AND CHINA CORD BLOOD CORPORATIONShare Charge Agreement • January 7th, 2016 • Golden Meditech Holdings LTD • Blank checks
PURCHASE AGREEMENTPurchase Agreement • May 8th, 2015 • Golden Meditech Holdings LTD • Blank checks • Hong Kong
PURCHASE AGREEMENTPurchase Agreement • May 8th, 2015 • Golden Meditech Holdings LTD • Blank checks • Hong Kong
LOCK-UP AGREEMENT among KKR CHINA HEALTHCARE INVESTMENT LIMITED and Golden Meditech STEM CELL (BVI) COMPANY LIMITED, andLock-Up Agreement • April 12th, 2012 • Golden Meditech Holdings LTD • Blank checks • New York
Golden Meditech Holdings LimitedPurchase Agreement • November 13th, 2015 • Golden Meditech Holdings LTD • Blank checks • Hong Kong
PLEDGE AGREEMENT Dated as of September 25, 2012 between GOLDEN MEDITECH HOLDINGS LIMITED as Pledgor and TAIWAN COOPERATIVE BANK, LTD., HONG KONG BRANCH as Security AgentPledge Agreement • October 4th, 2012 • Golden Meditech Holdings LTD • Blank checks • New York
PLEDGE AGREEMENT (this "Pledge Agreement"), dated as of September 25, 2012 between Golden Meditech Holdings Limited, an exempted company incorporated with limited liability under the laws of the Cayman Islands (the "Pledgor"), and Taiwan Cooperative Bank, Ltd., Hong Kong Branch, as security agent (the "Security Agent") for the Secured Parties.
Letter of GuaranteeLetter of Guarantee • December 30th, 2016 • Golden Meditech Holdings LTD • Blank checks
This Letter of Guarantee (this “Guarantee”) is issued for all the obligations of the Purchaser under the Share Purchase Agreement (the “SPA”) by and among Nanjing Ying Peng Hui Kang Medical Industry Investment Partnership (limited partnership) (the “Purchaser”), Golden Meditech Stem Cells (BVI) Company Limited (the “Seller”), and Golden Meditech Holdings Limited on December 30, 2016. To guarantee the performance by the Purchaser of all its obligations under the SPA, Yafei Yuan (a citizen of the People’s Republic of China (the “PRC”), with an ID card number being 320114196412230933 and the domicile at Room 1, Building 18, Middle Block, No. 71 Hai Fu Lane, Baixia District, Nanjing), being the undersigned, hereby unconditionally and irrevocably, undertakes to the Seller as follows:
JOINT FILING AGREEMENTJoint Filing Agreement • April 10th, 2017 • Golden Meditech Holdings LTD • Blank checks
In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the ordinary shares of China Cord Blood Corporation, a Cayman Islands company, and further agree that this Joint Filing Agreement may be included as an Exhibit to such joint filing.
Share Purchase AgreementShare Purchase Agreement • December 30th, 2016 • Golden Meditech Holdings LTD • Blank checks
The parties hereto each individually a “Party” or such “Party”, and collectively the “Parties”; and with respect to each other a “Party” or the other “Party”.
Re: Lock-Up Agreement dated April 12, 2012Lock-Up Agreement • May 2nd, 2012 • Golden Meditech Holdings LTD • Blank checks
We refer to the Lock-Up Agreement dated April 12, 2012 (the “Lock-Up Agreement”) among KKR China Healthcare Investment Limited and us. All capitalized terms not otherwise defined herein shall have the meaning ascribed to them in the Lock-Up Agreement.
Earnest Money AgreementEarnest Money Agreement • September 1st, 2016 • Golden Meditech Holdings LTD • Blank checks
Joint Filing AgreementJoint Filing Agreement • August 26th, 2015 • Golden Meditech Holdings LTD • Blank checks
In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13D referred to below) on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the ordinary shares, par value US$0.0001 per share, of China Cord Blood Corporation, and that this agreement may be included as an exhibit to such joint filing. This agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
Convertible note sale agreementConvertible Note Sale Agreement • November 3rd, 2015 • Golden Meditech Holdings LTD • Blank checks • Hong Kong
Framework Purchase AgreementFramework Purchase Agreement • November 5th, 2015 • Golden Meditech Holdings LTD • Blank checks
This Framework Purchase Agreement (this “Agreement”) is entered into by and between the following two parties in Nanjing on November 5, 2015:
Share Sale and Purchase AgreementShare Sale and Purchase Agreement • January 7th, 2016 • Golden Meditech Holdings LTD • Blank checks
The parties hereto each individually a “Party” or such “Party”, and collectively the “Parties”; and with respect to each other a “Party” or the other “Party”.
Profit Compensation AgreementProfit Compensation Agreement • December 30th, 2016 • Golden Meditech Holdings LTD • Blank checks
After friendly consultation, Party A and Party B hereby reach an agreement as follows for mutual observance in respect of the business performance commitment and compensation involved in the Proposed Transaction:
Supplemental Agreement to Share Purchase AgreementSupplemental Agreement to Share Purchase Agreement • November 14th, 2017 • Golden Meditech Holdings LTD • Blank checks • Beijing
This Supplemental Agreement to Share Purchase Agreement (this “Supplemental Agreement”) is made on November 14, 2017 (the “Execution Date”) by and among:
SHARE PURCHASE AGREEMENTShare Purchase Agreement • August 26th, 2015 • Golden Meditech Holdings LTD • Blank checks • Hong Kong
Share Sale Agreement Relating to China Cord Blood Corporation Golden Meditech Holdings Limited (Purchaser) Kam Yuen (Vendor)Share Sale Agreement • November 30th, 2015 • Golden Meditech Holdings LTD • Blank checks • Hong Kong
Underwriting AgreementUnderwriting Agreement • July 27th, 2015 • Golden Meditech Holdings LTD • Blank checks • Hong Kong
A As at the date of this Agreement, the authorised share capital of the Company is HK$600,000,000 divided into 3,000,000,000 Shares, of which 1,971,209,298 have been issued and are fully paid or credited as fully paid.
Memorandum of UnderstandingMemorandum of Understanding • December 30th, 2016 • Golden Meditech Holdings LTD • Blank checks
Second Supplementary Agreement to Earnest Money Agreement By and between Sanpower Group Co., Ltd. And Golden Meditech Holdings Limited Dated December 2016Second Supplementary Agreement to Earnest Money Agreement • December 30th, 2016 • Golden Meditech Holdings LTD • Blank checks
The Second Supplementary Agreement to Earnest Money Agreement (this “Agreement”) is entered on December 30, 2016 (“Execution Date”) by and between
US$65,000,000 FACILITY AGREEMENTFacility Agreement • October 4th, 2012 • Golden Meditech Holdings LTD • Blank checks • Hong Kong
*** Certain confidential information contained in this document, marked by brackets, has been omitted and filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Agreement to Terminate the Share Sale and Purchase AgreementAgreement to Terminate the Share Sale and Purchase Agreement • December 30th, 2016 • Golden Meditech Holdings LTD • Blank checks
TERMINATION DEEDTermination Deed • August 26th, 2015 • Golden Meditech Holdings LTD • Blank checks • Hong Kong
Supplementary Agreement to Earnest Money Agreement By and between Sanpower Group Co., Ltd., And Golden Meditech Holdings Limited Dated October 2016Supplementary Agreement to Earnest Money Agreement • October 31st, 2016 • Golden Meditech Holdings LTD • Blank checks
Joint Filing AgreementJoint Filing Agreement • April 27th, 2015 • Golden Meditech Holdings LTD • Blank checks
In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13D referred to below) on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the ordinary shares, par value US$0.0001 per share, of China Cord Blood Corporation, and that this agreement may be included as an exhibit to such joint filing. This agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
Letter of GuaranteeLetter of Guarantee • December 30th, 2016 • Golden Meditech Holdings LTD • Blank checks
This Letter of Guarantee (this “Guarantee”) is issued for all the obligations of the Purchaser under the Share Purchase Agreement (the “SPA”) by and among Nanjing Ying Peng Hui Kang Medical Industry Investment Partnership (limited partnership) (the “Purchaser”), Golden Meditech Stem Cells (BVI) Company Limited (the “Seller”), and Golden Meditech Holdings Limited on December 30, 2016. To guarantee the performance by the Purchaser of all its obligations under the SPA, Sanpower Group Co., Ltd. (“Sanpower”) (a limited liability company established and validly existing under the People’s Republic of China (“PRC”) laws, with its uniform social credit code being 913201002496667805), being the undersigned, hereby unconditionally and irrevocably, undertakes to the Seller as follows:
Agreement to Terminate the Profit Compensation AgreementTermination Agreement • December 30th, 2016 • Golden Meditech Holdings LTD • Blank checks
This Agreement to Terminate the Profit Compensation Agreement (this “Agreement”) is made on the 30th day of December 2016 by and between:
TERMINATION AGREEMENTTermination Agreement • August 26th, 2015 • Golden Meditech Holdings LTD • Blank checks • Hong Kong
Agreement to Terminate the Agreement to Purchase Assets by Share Issuance and Cash PaymentAgreement to Terminate the Agreement to Purchase Assets by Share Issuance and Cash Payment • December 30th, 2016 • Golden Meditech Holdings LTD • Blank checks
NOTE SUBSCRIPTION AGREEMENT among COM COMPANY LIMITED and GOLDEN MEDITECH HOLDINGS LIMITED and MR. KAM YUEN and BLUE OCEAN STRUCTURE INVESTMENT COMPANY LTD Dated December 4, 2015Note Subscription Agreement • December 7th, 2015 • Golden Meditech Holdings LTD • Blank checks • Hong Kong
NOW THEREFORE, in consideration of the foregoing, and the representations, warranties, and conditions set forth below, parties hereto, intending to be legally bound, hereby agree as follows:
Profit Compensation AgreementProfit Compensation Agreement • January 7th, 2016 • Golden Meditech Holdings LTD • Blank checks
For the purpose of protecting the interests of the small and medium-sized shareholders of Party A and after friendly consultation, Party A and Party B hereby reach an agreement as follows for mutual observance in respect of the business performance commitment and compensation involved in the Proposed Transaction:
Agreement to Purchase Assets by Share Issuance and Cash PaymentAgreement to Purchase Assets by Share Issuance and Cash Payment • January 7th, 2016 • Golden Meditech Holdings LTD • Blank checks
This Agreement to Purchase Assets by Share Issuance and Cash Payment (this “Agreement”) is made on the sixth day of January 2016 by and among:
AGREEMENT AS TO JOINT FILING OF SCHEDULE 13DJoint Filing Agreement • July 9th, 2009 • Golden Meditech CO LTD • Blank checks
